In our study, high levels of WNT5A bound to exosomes were associated with LUSC patients and shorter OS, while higher WNT5A in exosome-free serum predicted better survival associated with LUAD, suggesting that the context of WNT5A presentation and mode of secretion is crucial for its function in cancer [35, 36]. Here, WNT5A is linked to cancer.